Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 29Rectal Neoplasms 8Colonic Neoplasms 7Carcinoma, Hepatocellular 7Cholangiocarcinoma 5Stomach Neoplasms 4Neoplasm Metastasis 4Neoplasms 3Biliary Tract Neoplasms 3Adenocarcinoma Of Esophagus 3Ovarian Neoplasms 2Gastrointestinal Neoplasms 2Gallbladder Neoplasms 2Esophageal Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Solid Tumors 1Recurrence 1Pathologic Complete Response 1Pancreatic Neoplasms 1Neuroendocrine Tumors 1Lung Neoplasms 1Locally Advanced Rectal Cancer 1Locally Advanced Colorectal Carcinoma 1Liver Neoplasms 1Gastroesophageal Junction Adenocarcinoma 1Gastroesophageal Adenocarcinoma 1Gastro-enteropancreatic neuroendocrine tumor 1Endometrial Neoplasms 1Disease Progression 1Colorectal Cancer Metastatic 1

Interventions

camrelizumab 1apatinib 1Folfox protocol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Advanced Primary Liver Cancer × Folfox protocol × 1 year × Clear all
NCT03092895 2026-01-29

A Study of SHR-1210 in Combination With Apatinib or Chemotherapy in Subjects With Advanced PLC or BTC

Jiangsu HengRui Medicine Co., Ltd.

Phase 2 Completed
157 enrolled 17 charts
Gastrointestinal

Advanced Primary Liver Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡